InvestorsHub Logo
Followers 20
Posts 1031
Boards Moderated 0
Alias Born 10/17/2006

Re: gburgin post# 88761

Wednesday, 01/25/2017 4:09:42 PM

Wednesday, January 25, 2017 4:09:42 PM

Post# of 457590
The fact that there have been no challenges or counter claims indicates that all patent and exclusivity avenues continue to be covered by Anavex's top notch IP expertise.

And wouldn't it be cool if it also worked on cancer? We don't know that it doesn't.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News